Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Cryptosporidium parvum | inosine-5-monophosphate dehydrogenase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0192 | 0.0431 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.1475 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.1475 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0192 | 0.0431 | 0.5 |
Leishmania major | inosine-5-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1475 | 1 | 1 |
Brugia malayi | inosine-5'-monophosphate dehydrogenase family protein | 0.0134 | 0 | 0.5 |
Trypanosoma brucei | GMP reductase | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Toxoplasma gondii | IMP dehydrogenas | 0.0134 | 0 | 0.5 |
Echinococcus granulosus | inosine 5' monophosphate dehydrogenase 2 | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0192 | 0.0431 | 0.5 |
Echinococcus multilocularis | inosine 5' monophosphate dehydrogenase 2 | 0.0134 | 0 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.1475 | 1 | 1 |
Trypanosoma brucei | inosine-5'-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.1475 | 1 | 1 |
Schistosoma mansoni | inosine-5-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) | 0.0134 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1475 | 1 | 1 |
Leishmania major | guanosine monophosphate reductase | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0192 | 0.0431 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0192 | 0.0431 | 0.5 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.1475 | 1 | 1 |
Loa Loa (eye worm) | IMP dehydrogenase 1 | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | GMP reductase | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | GMP reductase | 0.0134 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 52 nM | Inhibition of recombinant Cryptosporidium parvum IMPDH assessed as production of NADH by fluorescence assay in presence of 0.05% BSA | ChEMBL. | 23324406 |
IC50 (binding) | = 54 nM | Inhibition of recombinant Cryptosporidium parvum IMPDH assessed as production of NADH by fluorescence assay | ChEMBL. | 23324406 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.